Organizations Select OnCore for Clinical Research Management - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Organizations Select OnCore for Clinical Research Management

Source: Company News Release

Forte Research Systems, a leading developer of specialized clinical trial management systems (CTMS) and enterprise research systems, is pleased to announce that six leading clinical research institutions selected the company’s flagship product, the OnCore® Enterprise Research system, in 2013.

The organizations chose OnCore to centrally manage clinical research operations, with half implementing the system across multidisciplinary research groups: 

  •     University of Colorado Denver
  •     University of Hawaii Cancer Center
  •     Baylor College of Medicine
  •     Hoosier Oncology Group
  •     Fox Chase Cancer Center
  •     Northside Hospital

The addition of the new customers strengthens the position of the OnCore system as the trusted market leader, having long been established as the nation’s most widely adopted enterprise-class research management system among academic medical centers, cancer centers, and research hospitals.

Standards-based systems a growing trend

The OnCore system has been developed and continually enhanced through collaboration with research organizations. This has resulted in a standards-based system that provides organizations with proven functionality for supporting best practices, while requiring less customization and internal resources. The rapid growth of the OnCore customer community reflects a trend among institutions to manage their clinical research operations with a standards-based system.

Tony O’Hare, Ph.D., Co-Founder and Chief Collaboration Officer at Forte, points to the company’s commitment to collaboration as a major contributor to the OnCore system’s success. “We listen to the needs of our customers and consistently deliver functionality that takes their operations to the next level,” he said.

In 2013, Forte released OnCore version 13.0, which was the largest release in the history of the system. It featured more than 150 enhancements, including redesigned electronic data capture (EDC) functionality that offers unrivaled support for managing electronic case report forms (eCRFs) and study data.

As a result of its successful product delivery, Forte has experienced substantial growth and in 2013 was ranked No. 2174 on Inc. magazine's sixth annual Inc. 500|5000, an exclusive ranking of the nation's fastest-growing private companies. It was the fourth consecutive year that Forte was ranked on the list.

About Forte Research Systems, Inc.

Founded in 2000 and headquartered in Madison, Wisconsin, Forte creates software and provides resources for better research compliance, patient safety, operational efficiency, and financial viability. Products include OnCore® Enterprise Research, Allegro® CTMS, and Overture™ EDC. Forte also hosts the Clinical Research Blog and the Research Resonance Network for sites and clinical research professionals pursuing excellence in clinical research operations.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Company News Release,
Click here